World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
74
Citations
32342
World Ranking
19273
National Ranking
274

Overview

Jorge Sierra is affiliated with the Autonomous University of Barcelona in Spain. Their research primarily focuses on the field of Medicine, with a specialization in Hematology, Oncology, Genetics, Molecular Biology, and Immunology.

The scientist's work encompasses a diverse range of topics, notably:

  • Acute Myeloid Leukemia Research
  • Hematopoietic Stem Cell Transplantation
  • Acute Lymphoblastic Leukemia research
  • CAR-T cell therapy research
  • Chronic Myeloid Leukemia Treatments
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Lymphoma Diagnosis and Treatment

Jorge Sierra has contributed extensively to the scientific literature with multiple publications. Some recent papers include:

  • "Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN" (2022) published in Blood
  • "International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data" (2022) published in Blood
  • "Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular Therapy" (2021) published in Transplantation and Cellular Therapy
  • "Follow-up of patients with R/R FLT3-mutation-positive AML treated with gilteritinib in the phase 3 ADMIRAL trial" (2022) published in Blood
  • "Genetic risk classification for adults with AML receiving less-intensive therapies: the 2024 ELN recommendations" (2024) published in Blood

Frequent co-authors in their collaborative work include:

  • Rodrigo Martino (30 co-authored publications)
  • Jordi Esteve (24 co-authored publications)
  • Irene García-Cadenas (21 co-authored publications)
  • Josep Nomdedéu (21 co-authored publications)
  • Montserrat Arnán (21 co-authored publications)

The most common publication venues for Jorge Sierra's research are:

  • Blood (33 publications)
  • Transplantation and Cellular Therapy (10 publications)
  • Bone Marrow Transplantation (7 publications)
  • HemaSphere (7 publications)
  • European Journal Of Haematology (7 publications)

Best Publications

  • Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel

    Hartmut Döhner;Elihu Estey;David Grimwade;Sergio Amadori

  • Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet.

    Hartmut Dohner;Elihu H. Estey;Sergio Amadori;Frederick R. Appelbaum

  • Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation

    Richard M. Stone;Sumithra J. Mandrekar;Ben L. Sanford;Kristina Laumann

  • Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials.

    John Koreth;Richard Schlenk;Kenneth J. Kopecky;Sumihisa Honda

  • Effect of Age on Outcome of Reduced-Intensity Hematopoietic Cell Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission or With Myelodysplastic Syndrome

    Brian L. McClune;Daniel J. Weisdorf;Tanya L. Pedersen;Gisela Tunes da Silva

  • Antilymphocyte globulin for prevention of chronic graft-versus-host disease

    Nicolaus Kröger;Carlos Solano;Christine Wolschke;Giuseppe Bandini

  • Retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic hematopoietic stem cell transplantation using HLA-identical sibling donors in myelodysplastic syndromes.

    Rodrigo Martino;Simona Iacobelli;Ronald Brand;Thekla Jansen

  • Safety, Pharmacokinetics, and Preliminary Clinical Activity of Inotuzumab Ozogamicin, a Novel Immunoconjugate for the Treatment of B-Cell Non-Hodgkin's Lymphoma: Results of a Phase I Study

    Anjali Advani;Bertrand Coiffier;Myron S. Czuczman;Martin Dreyling

  • Transplantation of Marrow Cells From Unrelated Donors for Treatment of High-Risk Acute Leukemia: The Effect of Leukemic Burden, Donor HLA- Matching, and Marrow Cell Dose

    Jorge Sierra;Barry Storer;John A. Hansen;Jean W. Bjerke

  • The European LeukemiaNet AML Working Party consensus statement on allogeneic HSCT for patients with AML in remission: an integrated-risk adapted approach

    Jan J. Cornelissen;Alois Gratwohl;Richard F. Schlenk;Jorge Sierra

  • Prophylaxis and treatment of GVHD: EBMT–ELN working group recommendations for a standardized practice

    T. Ruutu;A. Gratwohl;T. De Witte;B. Afanasyev

  • Interleukin-3 receptor alpha chain (CD123) is widely expressed in hematologic malignancies.

    Luz Munoz;Josep F. Nomdedeu;Olga Lopez;Maria J. Carnicer

  • Impact of FLT3 Internal Tandem Duplication on the Outcome of Related and Unrelated Hematopoietic Transplantation for Adult Acute Myeloid Leukemia in First Remission: A Retrospective Analysis

    Salut Brunet;Myriam Labopin;Jordi Esteve;Jan Cornelissen

  • Favorable outcome of patients with acute myeloid leukemia harboring a low-allelic burden FLT3-ITD mutation and concomitant NPM1 mutation: relevance to post-remission therapy.

    Marta Pratcorona;Salut Brunet;Josep Nomdedéu;Josep Maria Ribera

  • Bone marrow transplantation from HLA-identical siblings as treatment for myelodysplasia.

    Jorge Sierra;Waleska S. Pérez;Ciril Rozman;Enric Carreras

  • Sustained Remissions of High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome After Reduced-Intensity Conditioning Allogeneic Hematopoietic Transplantation: Chronic Graft-Versus-Host Disease Is the Strongest Factor Improving Survival

    David Valcárcel;Rodrigo Martino;Dolores Caballero;Jesus Martin

  • Prospective study of the incidence, clinical features, and outcome of symptomatic upper and lower respiratory tract infections by respiratory viruses in adult recipients of hematopoietic stem cell transplants for hematologic malignancies

    Rodrigo Martino;Rocío Parody Porras;Nuria Rabella;John V. Williams

  • Prognostic factors affecting long-term outcome after stem cell transplantation in Hodgkin's lymphoma autografted after a first relapse

    A. Sureda;M. Constans;A. Iriondo;R. Arranz

  • Evidence for a graft-versus-leukemia effect after allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning in acute myelogenous leukemia and myelodysplastic syndromes

    Rodrigo Martino;Marı́a Dolores Caballero;José Antonio Pérez Simón;Carmen Canals

  • Severe Infections after Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation in Adults: Comparison of Cord Blood Transplantation with Peripheral Blood and Bone Marrow Transplantation

    Rocío Parody;Rodrigo Martino;Montserrat Rovira;Lourdes Vazquez

Frequent Co-Authors

Rodrigo Martino
Rodrigo Martino Hospital de Sant Pau
Anna Sureda
Anna Sureda Autonomous University of Barcelona
Arnon Nagler
Arnon Nagler Sheba Medical Center
Miguel A. Sanz
Miguel A. Sanz University of Valencia
Josep-Maria Ribera
Josep-Maria Ribera Autonomous University of Barcelona
Myriam Labopin
Myriam Labopin Université Paris Cité
Enric Carreras
Enric Carreras University of Barcelona
Guillermo Sanz
Guillermo Sanz Hospital Universitari i Politècnic La Fe
Dietger Niederwieser
Dietger Niederwieser Leipzig University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Medicine is only one path toward a rewarding healthcare career. Many students and professionals are also exploring related online degrees for greater flexibility and specialization. For those interested in leadership or administrative roles, cahme accredited online healthcare administration programs provide a quality route to advanced management positions in healthcare settings.

Registered nurses seeking career advancement without the traditional clinical requirements might consider an rn to bsn without clinicals program. These options offer academic progression and new opportunities with minimal interruption to your work schedule.

For nurses aiming for the highest levels of practice, a Doctor of Nursing Practice (DNP) can open doors to leadership and specialized roles. Many schools offer flexible dnp online programs, allowing completion in less time. Cost-conscious students can also explore the cheapest online dnp programs for high-quality education that fits their budget.

Exploring these related pathways can lead to a dynamic career in healthcare, whether your interest is clinical practice, management, or executive leadership.

Best Scientists Citing Jorge Sierra

Trending Scientists

Recently Published Articles